Evaluating NGS technologies for in-house comprehensive genomic profiling
                  11/13/2024   |  
                  
                  
                    
                  
                    
                      Research
                      
                    
                  
                  
                
                
                  In everyday practice, it is common for pathology labs to evaluate >50% cytological specimens across solid tumors especially in lung and pancreatic...
                
                
              - 
              
              2021 European Association for Haematopathology Virtual Meeting Highlights2021 EAHP Symposium Overview As part of the 20th Meeting of the European Association for Haematopath...
- 
              
              NGS Enables Precision Oncology in Community-Based HospitalsNext-generation sequencing (NGS) technology has changed cancer treatment by enabling pathologists an...
- 
              
              How Diagnostics can Revolutionize Patient Care: Insights from the Precision Medicine Leader SummitPrecision medicine is a holistic approach to healthcare that combines knowledge of an individuals’ g...
- 
              
              University of Munich Evaluates the Oncomine Comprehensive Plus Assay for HRD DetectionOur OncomineWorld event in 2021 brought thousands of professionals together from around the world to...
- 
              
              Case Study: High-Quality, Cost-Effective Genomic Testing and Genetic Profiling using NGSIn a recent case study interview, pathologist Federico Jauk, head of the Sequencing Laboratory at th...
- 
              
              Q&A: An Inside Look at Immune Repertoire Assay Development with Dr. Geoffrey LowmanDr. Geoffrey Lowman Senior Staff Scientist, Molecular Biology, Clinical Sequencing Division Thermo F...
- 
              
              UAB Study Evaluates the Oncomine Myeloid Research Assay GX on the Genexus SystemPerformance of the Oncomine Myeloid Research Assay GX Craig Mackinnon, MD, PhD, Director of Genomic ...
- 
              
              Let’s Do It Ourselves - A global expert consensus is emerging: by retaining oncology biomarker testing in-house, healthcare management and patient care benefit significantlyOver the last decade, precision oncology therapies dependent on biomarker-based diagnostics have pro...
- 
              
              A Comprehensive Answer for Cancer: Is Comprehensive Genomic Profiling Always the Right Approach?What is comprehensive genomic profiling (CGP)? CGP is the simultaneous detection of all classes of g...
